Evercore ISI Group analyst Jonathan Miller initiates coverage on Entrada Therapeutics (NASDAQ:TRDA) with a Outperform rating.
Evercore ISI Group Initiates Coverage On Entrada Therapeutics with Outperform Rating
Evercore ISI Group analyst Jonathan Miller initiates coverage on Entrada Therapeutics (NASDAQ:TRDA) with a Outperform rating.
Related Posts
Roth Capital Maintains Buy on Netlist, Raises Price Target to $6
Roth Capital analyst Suji Desilva maintains Netlist (OTC:NLST) with a Buy and raises the price target from $4 to $6.
Dukosi Limited Selects Keysight To Develop Battery For Project
Battery management technology supplier Dukosi Limited chose Keysight Technologies Inc (NYSE:KEYS) to support the development of battery management integrated circuits for its…
Shark Tank’s O’Leary Tussles With CNBC Over $11M Loss From FTX Fallout: Here’s What He Told Benzinga About His Next Move Involving An ‘Army Of Lawyers’
Renowned "Shark Tank" investor Kevin O'Leary is feeling the pain from the FTX fallout to the tune of $11 million and he's not willing to accept that the money made out like Harry Houdini and disappeared.